Lionel Pochet

Computer-aided and fragment-based drug design

Discovery of new therapeutic agents using computer-aided and fragment-based drug design approaches

Dr. Lionel Pochet PharmD, PhD

UNamur, Department of pharmacy 

Member of the Namur Medicine & Drug Innovation Center (NAMEDIC)

Member of the Namur Thrombosis & Hemostasis Center (NTHC)

Research portal UNamur  |  ORCID  |  ResearchGate  |  LinkedIn

Expertise and research interests

Dr. Lionel Pochet has a solid expertise on medicinal chemistry in general, and in the rational design and evaluation of new serine protease inhibitors, in particular, using computer-aided and fragment-based drug design approaches. During his research, he designed coumarin derivatives as covalent inhibitors. In the last decade, first during his postdoc and then, in collaboration with Prof. Marianne Fillet (ULiège), Prof. Raphaël Frédérick (UCLouvain) and Prof. Johan Wouters (UNamur), he was involved in the development of analytical methodologies in support of medicinal chemistry projects.

Group members

PhD students: Xavier Garcia Llinas and Amandine Traina

Research projects

  • ONGOING  Structure-based drug design and synthesis of selective small-molecular-weight inhibitors of FXIIa, an attractive target from the intrinsic coagulation cascade. Ongoing PhD thesis by Amandine Traina. Under co-supervision by Prof. Steve Lanners (promoter) and Dr. Lionel Pochet (co-promoter).
  • ONGOING  Design and synthesis of covalent disruptors to target the self-association of proteins. Ongoing PhD thesis by Xavier Garcia Llinas. Under co-supervision by Dr. Lionel Pochet (promoter) and Prof. Johan Wouters (co-promoter). 

Selected publications

Davoine C, Traina A, Evrard J, Lanners S, Fillet M, Pochet L. Coumarins as factor XIIa inhibitors: Potency and selectivity improvements using a fragment-based strategy. Eur J Med Chem. 2023 Jul 16;259:115636.

Davoine C, Pochet L, Fillet M. Advances in analytical technologies detecting and characterizing noncovalent interactions for fragment-based drug discovery. TrAC Trends in Analytical Chemistry, 2023 Volume 166, 117161.

Davoine C, Fillet M, Pochet L. Capillary electrophoresis as a fragment screening tool to cross-validate hits from chromogenic assay: Application to FXIIa. Talanta. 2021. Volume 226, 122163.

Davoine C, Bouckaert C, Fillet M, Pochet L. Factor XII/XIIa inhibitors: Their discovery, development, and potential indications. Eur J Med Chem. 2020 Aug 20;208:112753.

Ameryckx A, Pochet L, Wang G, Yildiz E, Saadi BE, Wouters J, Van Bambeke F, Frédérick R. Pharmacomodulations of the benzoyl-thiosemicarbazide scaffold reveal antimicrobial agents targeting d-alanyl-d-alanine ligase in bacterio. Eur J Med Chem. 2020 Aug 15;200:112444.

Farcaş E, Hanson J, Pochet L, Fillet M. Capillary electrophoretic mobility shift displacement assay for the assessment of weak drug-protein interactions. Anal Chim Acta. 2018 Nov 30;1034:214-222.

Farcaş E, Bouckaert C, Servais AC, Hanson J, Pochet L, Fillet M. Partial filling affinity capillary electrophoresis as a useful tool for fragment-based drug discovery: A proof of concept on thrombin. Anal Chim Acta. 2017 Sep 1;984:211-222.

Bouckaert C, Zhu S, Govers-Riemslag JWP, Depoorter M, Diamond SL, Pochet L. Discovery and assessment of water soluble coumarins as inhibitors of the coagulation contact pathway. Thromb Res. 2017 Jul 19;157:126-133.

Bouckaert C, Serra S, Rondelet G, Dolušić E, Wouters J, Dogné JM, Frédérick R, Pochet L. Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors. Eur J Med Chem. 2016 Jan 16;110:181-194.